Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 250 mg - tablet - excipient ingredients: macrogol 8000; hypromellose; poloxamer; titanium dioxide; stearic acid - famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet - excipient ingredients: titanium dioxide; hypromellose; macrogol 8000; stearic acid; poloxamer - famciclovir is indicated for:. - the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.. - the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. - suppression of recurrent genital herpes.. - the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir is indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster;. - treatment of recurrent herpes simplex;. - suppression of recurrent herpes simplex.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 500 mg - tablet - excipient ingredients: titanium dioxide; poloxamer; stearic acid; macrogol 8000; hypromellose - famciclovir is indicated for:,= treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients.,= treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,= suppression of recurrent genital herpes.,= treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for:,= treatment of uncomplicated herpes zoster,= treatment of recurrent herpes simplex,= suppression of recurrent herpes simplex.

Egyesült Államok - angol - NLM (National Library of Medicine)

american health packaging - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 500 mg - herpes labialis (cold sores) famciclovir tablets are indicated for the treatment of recurrent herpes labialis. genital herpes recurrent episodes famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles) famciclovir tablets are indicated for the treatment of herpes zoster. the efficacy of famciclovir when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes famciclovir tablets are indicated for the treatment of recurrent episodes of orolabial or genital herpes in hiv-infected adu

Egyesült Államok - angol - NLM (National Library of Medicine)

physicians total care, inc. - famciclovir (unii: qic03ani02) (famciclovir - unii:qic03ani02) - famciclovir 500 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes: famciclovir tablets are indicated for the treatment of recurrent episodes of orolabial or genital herpes in hiv-infected adults. the

Egyesült Államok - angol - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 125 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis in adult patients. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in adult patients. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster in adult patients. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes : famciclovir tab

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; hyprolose; purified water; microcrystalline cellulose; silicon dioxide; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients aged 18 years and over.